LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1537579
KCNQ1OT1/miR-217/ZEB1 feedback loop facilitates cell migration and epithelial-mesenchymal transition in colorectal cancer
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1579959
A regulatory circuit of circ-MTO1/miR-17/QKI-5 inhibits the proliferation of lung adenocarcinoma
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1598762
Research progress of circular RNAs in lung cancer
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1523848
FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1529101
Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gαq and Gα11 and kill uveal melanoma cells
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1551747
Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1595283
Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1538612
The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1598766
LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1550568
EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1595276
MiR-202-5p/PTEN mediates doxorubicin-resistance of breast cancer cells via PI3K/Akt signaling pathway
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1591674
Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1673098
Prior exposure of pancreatic tumors to [sorafenib + vorinostat] enhances the efficacy of an anti-PD-1 antibody
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1507258
Weighted gene co-expression network analysis and prognostic analysis identifies hub genes and the molecular mechanism related to head and neck squamous cell carcinoma
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1564560
LINC01133 promotes the progression of cervical cancer by sponging miR-4784 to up-regulate AHDC1
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1647058
Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant setting
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1583533
CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1685157
Serum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1595277
Cancer-associated fibroblasts promote colorectal cancer progression by secreting CLEC3B
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1591122
Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1617566
Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1680057
The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1595280
The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1529093
Visfatin is involved in the cisplatin resistance of osteosarcoma cells via upregulation of Snail and Zeb1
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1591675
PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumors
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1529114
Tumor regression after combination of radiation and PD-1 antibody nivolumab treatment in a patient with metastatic mediastinal leiomyosarcoma: a case report
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1537577
Adeno-associated virus 2 mediated gene transfer of vascular endothelial growth factor Trap: a new treatment option for glioma
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1504725
Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1579962
Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1580414
Discovery and mechanisms of host defense to oncogenesis: targeting the β-defensin-1 peptide as a natural tumor inhibitor
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1564564
GSK343 induces programmed cell death through the inhibition of EZH2 and FBP1 in osteosarcoma cells
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1680061
De novo MET amplification promotes intrinsic resistance to first-generation EGFR tyrosine kinase inhibitors
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1617568
Sodium chloride (NaCl) potentiates digoxin-induced anti-tumor activity in small cell lung cancer
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1504723
Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1595278
Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1617570
2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1537578
Montelukast enhances cytocidal effects of carfilzomib in multiple myeloma by inhibiting mTOR pathway
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1529112
SEMA4D under the posttranscriptional regulation of HuR and miR-4319 boosts cancer progression in esophageal squamous cell carcinoma
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1669996
BMSC-derived leptin and IGFBP2 promote erlotinib resistance in lung adenocarcinoma cells through IGF-1R activation in hypoxic environment
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1665952
Combined α-programmed death-1 monoclonal antibody blockade and fractionated radiation therapy reduces tumor growth in mouse EL4 lymphoma
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1550569
Unexpected favorable outcome to etoposide and cisplatin in a small cell lung cancer transformed patient: a case report
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1617561
Correction notice
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1699718
Discovery platform for inhibitors of IgH gene enhancer activity
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1538615
Successful treatment of a BRAF V600E-mutant extracranial metastatic anaplastic oligoastrocytoma with vemurafenib and everolimus
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2018.1529115
Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML)
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1579958
Two dichloric compounds inhibit in vivo U87 xenograft tumor growth
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1632131
Comparison of 21-gene assay and St.Gallen International Expert Consensus in the treatment decision for patients with early invasive breast cancers
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1669994
A case of primary pulmonary atypical carcinoid with EML4-ALK rearrangement
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1665957
Meningeal metastasis of a malignant peritoneal mesothelioma: A case report and literature review
来源期刊:Cancer Biology & TherapyDOI:10.1080/15384047.2019.1647053